• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• Twitter
• Newsletter

Advertisement

Organisation › Details

Takeda (Group)

Located in Osaka, Japan, Takeda is a research based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to striving toward better health for patients worldwide through leading innovation in medicine. *

 

	Start	1990-01-01 existent
	Industry	pharmaceutical
	Street	1-1 Doshomachi 4-chome Chuo-ku
	City	540-8645 Osaka
	Tel	+81-6-6204-2111
		Address record changed: 2020-12-02
Basic data	Employees	H: 10,001 to 50,00 (2016-03-31)
	Currency	USD
	Annual sales	16,137,304,000 (revenue, consolidated (15/16) 2016-03-31)
	Profit	745,357,000 (2016-03-31)
	Cash	4,030,589,000 (2016-03-31)
		* Document for �About Section�:
		Record changed: 2021-12-31

Advertisement

More documents for Takeda (Group)

• [1] Integra Thepeutics S.L.. (12/2/21). "Press Release: Integra Tx Secures €4.5 Million in Funding from Advent France Biotechnology, Invivo Capital and Takeda Ventures". Barcelona....
• [2] GammaDelta Therapeutics Ltd.. (10/27/21). "Press Release: Takeda to Acquire GammaDelta Therapeutics to Accelerate Development of Allogeneic gdT Cell Therapies Addressing Solid Tumors". Osaka & London....
• [3] Panekès Partners SGR S.p.A.. (9/27/21). "Press Release: Panakès Partners Appoints Dr. Rob Woodman as Partner to Lead Biotech Investment". Milan....
• [4] Transine Therapeutics Ltd.. (6/2/21). "Press Release: Transine Therapeutics Closes Extended Seed Funding of £9.1 Million Co-led by Takeda Ventures, Inc. and the Dementia Discovery Fund to Advance Its Novel Class of Therapeutic RNAs". Cambridge....
• [5] Evotec SE. (3/22/21). "Press Release: Evotec and Takeda Enter Strategic RNA Targeting Drug Discovery and Development Alliance". Hamburg....
• [6] Enterome S.A.. (9/23/20). "Press Release: Enterome Announces First Patient Dosed in Phase 2a Trial of Sibofimloc in Crohn’s Disease". Paris & Cambridge, MA....
• [7] Engitix Ltd.. (8/25/20). "Press Release: Engitix Signs Collaboration and Licensing Agreement with Takeda to Develop Anti-Fibrotic Therapies in Advanced Liver Diseases". London....
• [8] Egle Therapeutics S.A.S.. (6/11/20). "Press Release: Egle Therapeutics Enters Into a Corporate Strategic Research Alliance with Takeda to Uncover Novel Tumor-specific Regulatory T-cell Targets and Develop Unique Anti-Suppressor-Based Immunotherapies". Pa...
• [9] Evotec SE. (4/6/20). "Press Release: Evotec and Takeda Enter into Multi-year Gene Therapy Research Alliance". Hamburg....
• [10] Evotec SE. (3/26/20). "Press Release: Evotec SE Fiscal Year 2019 Results". Hamburg....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2022. Made in Germany.